Shukla, Suneet

The Inhibitor Ko143 Is Not Specific for ABCG2

Weidner, L. D., Zoghbi, S. S., Lu, S., Shukla, S., Ambudkar, S. V., Pike, V. W., Mulder, J., Gottesman, M. M., Innis, R. B., & Hall, M. D. (2015) · The Journal of Pharmacology and Experimental Therapeutics

Drug Transport and Resistance MechanismsBarrier Structure and Function Studies

Cited by 141

Functional Characterization of Candida albicans ABC Transporter Cdr1p

Shukla, S., Saini, P., Smriti, Jha, S., Ambudkar, S. V., & Prasad, R. (2003) · Eukaryotic Cell

Drug Transport and Resistance MechanismsAntifungal resistance and susceptibility

Cited by 135

Inhibition of ABCG2-mediated transport by protein kinase inhibitors with a bisindolylmaleimide or indolocarbazole structure

Robey, R. W., Shukla, S., Steadman, K., Obrzut, T., Finley, E. M., Ambudkar, S. V., & Bates, S. E. (2007) · Molecular Cancer Therapeutics

Drug Transport and Resistance MechanismsPharmacogenetics and Drug Metabolism

Cited by 61

Screening Compounds with a Novel High-Throughput ABCB1-Mediated Efflux Assay Identifies Drugs with Known Therapeutic Targets at Risk for Multidrug Resistance Interference

Ansbro, M. R., Shukla, S., Ambudkar, S. V., Yuspa, S. H., & Li, L. (2013) · PLoS ONE

Drug Transport and Resistance MechanismsAntibiotic Resistance in Bacteria

Cited by 54